Clinical trial transparency tools provider TrialAssure has launched a new software-as-a-service (SaaS) application called ANONYMIZE DS for automatic anonymization of trial datasets.

The application is designed to anonymize actual data using techniques that enable customisation for individual datasets. It also allocates a risk score for re-identification of this data depending on thresholds defined by the sponsor.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Sponsors will be able to entirely configure the TrialAssure application, which is said to boost efficiency by considering the emerging machine learning technology field.

In addition, ANONYMIZE DS saves time for sponsors by facilitating building of a custom, reusable variables library. The application allows users to reapply these same anonymization rules across trials.

This approach is expected to save time as well as resources, particularly in case of larger drug development pipelines involving different studies sharing the same variables.

Data fields set by the sponsors for anonymization are analysed and assigned a risk score. This analysis by ANONYMIZE DS can be saved and replicated.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

TrialAssure chief information officer Mohamad Zahreddine said: “The pharmaceutical industry is moving towards sharing data more openly. Health authorities and scientific journal editors alike may require greater levels of data transparency in the not-so-distant future.”

The new application is part of the company’s fully-integrated suite of transparency tools intended to enable data sharing among health authorities without compromising patient privacy.

Zahreddine noted: “In the age of big data, research organizations can leverage pre-existing, anonymized data to speed-up the development process for life-changing medicines.”

Currently, the TrialAssure ANONYMIZE DS application is available in limited release, with full deployment planned for coming months.